Get started
Author

Barbara M. A. van Vugt‐Lussenburg

Observed names: B. M. A. Van Vugt-Lussenburg, B. M. A. van Vugt-Lussenburg, B. M. A. van Vugt‐Lussenburg, B.M. van Vugt-Lussenburg, B.M.A. van Vugt, B.M.A. van Vugt-Lussenburg, Barbara A. van Vugt-Lussenburg, Barbara M A van Vugt-Lussenburg, Barbara M. A. van Vugt-Lussenburg, Barbara M.A. Lussenburg, Barbara M.A. van Vught-Lussenburg, Barbara M.A. van Vugt-Lussenburg, Barbara MA van Vugt-Lussenburg, Barbara Medea Alice van Vugt-Lussenburg, Barbara van Vugt-Lussenburg, Barbara van Vugt‐Lussenburg
ORCID: 0000-0001-9968-0402
Observed ORCID: 0000-0001-9968-0402
OpenAlex ID: A5068227082
Are Structural Analogues to Bisphenol A Safe Alternatives?
2014 · Anna Kjerstine Rosenmai, Marianne Dybdahl, et al. · Toxicological Sciences · 453
Development of a panel of high-throughput reporter-gene assays to detect genotoxicity and oxidative stress
2013 · Sander C. van der Linden, Anne R.M. von Bergh, et al. · Mutation Research/Genetic Toxicology and Environmental Mutagenesis · 127
Identification of Critical Residues in Novel Drug Metabolizing Mutants of Cytochrome P450 BM3 Using Random Mutagenesis
2007 · Barbara M. A. van Vugt-Lussenburg, Eva Stjernschantz, et al. · Journal of Medicinal Chemistry · 108
Evaluation of an alternative in vitro test battery for detecting reproductive toxicants
2013 · A.H. Piersma, S. Bosgra, et al. · Reproductive Toxicology · 104
Fluorinated alkyl substances and technical mixtures used in food paper‐packaging exhibit endocrine‐related activity in vitro
2016 · A. K. Rosenmai, C. Taxvig, et al. · Andrology · 99
PDF
Heterotropic and homotropic cooperativity by a drug-metabolising mutant of cytochrome P450 BM3
2006 · Barbara M.A. van Vugt-Lussenburg, Micaela C. Damsten, et al. · Biochemical and Biophysical Research Communications · 94
https://www.altex.org/index.php/altex/article/view/1339
2019 · Alice Krebs, Tanja Waldmann, et al. · ALTEX · 92
Application of drug metabolising mutants of cytochrome P450 BM3 (CYP102A1) as biocatalysts for the generation of reactive metabolites
2007 · Micaela C. Damsten, Barbara M.A. van Vugt-Lussenburg, et al. · Chemico-Biological Interactions · 91
Evaluation of alkoxyresorufins as fluorescent substrates for cytochrome P450 BM3 and site-directed mutants
2005 · Barbara M.A. Lussenburg, Lloyd C. Babel, et al. · Analytical Biochemistry · 58
Read-across and new approach methodologies applied in a 10-step framework for cosmetics safety assessment – A case study with parabens
2022 · Gladys Ouedraogo, Camilla Alexander-White, et al. · Regulatory Toxicology and Pharmacology · 56
Neurotoxicity and underlying cellular changes of 21 mitochondrial respiratory chain inhibitors
2021 · Johannes Delp, Andrea Cediel-Ulloa, et al. · Archives of Toxicology · 55
PDF
The EU-ToxRisk method documentation, data processing and chemical testing pipeline for the regulatory use of new approach methods
2020 · Alice Krebs, Barbara M. A. van Vugt-Lussenburg, et al. · Archives of Toxicology · 55
PDF
Incorporation of metabolic enzymes to improve predictivity of reporter gene assay results for estrogenic and anti-androgenic activity
2017 · Barbara M.A. van Vugt-Lussenburg, Rosan B. van der Lee, et al. · Reproductive Toxicology · 48
PDF
Integrate mechanistic evidence from new approach methodologies (NAMs) into a read-across assessment to characterise trends in shared mode of action
2021 · Sylvia E. Escher, Alejandro Aguayo-Orozco, et al. · Toxicology in Vitro · 45
PDF
Influence of phenylalanine 120 on cytochrome P450 2D6 catalytic selectivity and regiospecificity: crucial role in 7-methoxy-4-(aminomethyl)-coumarin metabolism
2004 · Peter H.J. Keizers, Barbara M.A. Lussenburg, et al. · Biochemical Pharmacology · 45
Molecular Modeling-Guided Site-Directed Mutagenesis of Cytochrome P450 2D6
2006 · Chris de Graaf, Chris Oostenbrink, et al. · Current Drug Metabolism · 44
Evaluation of an alternative in vitro test battery for detecting reproductive toxicants in a grouping context
2014 · E. Dinant Kroese, Sieto Bosgra, et al. · Reproductive Toxicology · 41
Structural rationalization of novel drug metabolizing mutants of cytochrome P450 BM3
2007 · Eva Stjernschantz, Barbara M. A. van Vugt‐Lussenburg, et al. · Proteins Structure Function and Bioinformatics · 41
A Panel of Quantitative Calux® Reporter Gene Assays for Reliable High‐Throughput Toxicity Screening of Chemicals and Complex Mixtures
2013 · Bart van der Burg, Sander van der Linden, et al. · Wiley eBooks · 38
Biochemical Similarities and Differences between the Catalytic [4Fe-4S] Cluster Containing Fumarases FumA and FumB from Escherichia coli
2013 · Barbara M. A. van Vugt-Lussenburg, Laura van der Weel, et al. · PLoS ONE · 36
PDF
Effect-based assessment of persistent organic pollutant and pesticide dumpsite using mammalian CALUX reporter cell lines
2015 · B. Pieterse, I. J. C. Rijk, et al. · Environmental Science and Pollution Research · 34
“ Commandeuring ” Xenobiotic Metabolism: Advances in Understanding Xenobiotic Metabolism
2022 · Barbara M. A. van Vugt-Lussenburg, Liliana Capinha, et al. · Chemical Research in Toxicology · 31
Activation of the anticancer drugs cyclophosphamide and ifosfamide by cytochrome P450 BM3 mutants
2014 · Galvin Vredenburg, Shalenie den Braver-Sewradj, et al. · Toxicology Letters · 31
The role of phenylalanine 483 in cytochrome P450 2D6 is strongly substrate dependent
2005 · Barbara M.A. Lussenburg, Peter H.J. Keizers, et al. · Biochemical Pharmacology · 31
A high throughput screening system for predicting chemically-induced reproductive organ deformities
2014 · Bart van der Burg, Bart Pieterse, et al. · Reproductive Toxicology · 30
Works count: 44
Citation count: 2,125
H-index: 27
I10-index: 36
Year
Topic
Type